Powl Brian T. 4
4 · Kura Oncology, Inc. · Filed Nov 14, 2025
Insider Transaction Report
Form 4
Powl Brian T.
Chief Commercial Officer
Transactions
- Award
Common Stock
2025-11-13+48,900→ 148,576 total - Sale
Common Stock
2025-11-14$11.18/sh−8,887$99,329→ 139,689 total
Footnotes (2)
- [F1]Grant of Restricted Stock Units (RSUs). The RSUs vest 50% immediately and 50% on 11/13/26.
- [F2]Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 11/13/25.